PONZONI, MAURILIO
 Distribuzione geografica
Continente #
AS - Asia 11.042
EU - Europa 10.446
NA - Nord America 8.816
SA - Sud America 3.140
Continente sconosciuto - Info sul continente non disponibili 393
AF - Africa 245
OC - Oceania 25
Totale 34.107
Nazione #
US - Stati Uniti d'America 8.313
RU - Federazione Russa 6.063
SG - Singapore 3.811
CN - Cina 3.296
BR - Brasile 2.549
HK - Hong Kong 1.509
SE - Svezia 1.181
IT - Italia 1.151
VN - Vietnam 1.094
FR - Francia 550
DE - Germania 418
BD - Bangladesh 403
GB - Regno Unito 272
AR - Argentina 238
CA - Canada 212
IN - India 186
FI - Finlandia 182
MX - Messico 144
AT - Austria 125
EC - Ecuador 113
ID - Indonesia 107
IE - Irlanda 102
JP - Giappone 102
NL - Olanda 80
TR - Turchia 76
IQ - Iraq 74
ES - Italia 71
ZA - Sudafrica 71
PL - Polonia 67
CO - Colombia 64
PY - Paraguay 51
MA - Marocco 47
CL - Cile 40
VE - Venezuela 38
PK - Pakistan 36
SA - Arabia Saudita 36
UA - Ucraina 35
MY - Malesia 31
UZ - Uzbekistan 29
KE - Kenya 27
TN - Tunisia 25
EG - Egitto 24
AE - Emirati Arabi Uniti 23
KR - Corea 23
PE - Perù 23
AU - Australia 21
JM - Giamaica 20
IR - Iran 19
PT - Portogallo 19
PH - Filippine 18
CR - Costa Rica 16
LT - Lituania 16
DZ - Algeria 15
HN - Honduras 15
JO - Giordania 15
BE - Belgio 14
GT - Guatemala 14
TT - Trinidad e Tobago 14
IL - Israele 13
MD - Moldavia 13
NP - Nepal 13
OM - Oman 13
UY - Uruguay 13
LB - Libano 12
SV - El Salvador 12
AL - Albania 11
DO - Repubblica Dominicana 11
BB - Barbados 10
BO - Bolivia 10
KZ - Kazakistan 10
AZ - Azerbaigian 9
CH - Svizzera 9
KW - Kuwait 9
NI - Nicaragua 9
PS - Palestinian Territory 9
TW - Taiwan 9
CZ - Repubblica Ceca 8
CY - Cipro 7
ET - Etiopia 7
PR - Porto Rico 7
BH - Bahrain 6
BY - Bielorussia 6
CI - Costa d'Avorio 6
SY - Repubblica araba siriana 6
BG - Bulgaria 5
GG - Guernsey 5
HR - Croazia 5
HU - Ungheria 5
LV - Lettonia 5
NO - Norvegia 5
PA - Panama 5
RS - Serbia 5
TH - Thailandia 5
YE - Yemen 5
AO - Angola 4
BA - Bosnia-Erzegovina 4
DK - Danimarca 4
GE - Georgia 4
KH - Cambogia 4
NG - Nigeria 4
Totale 33.650
Città #
Dallas 1.642
Singapore 1.549
Hong Kong 1.497
Moscow 1.324
Ashburn 891
San Jose 856
Shanghai 598
Council Bluffs 560
Hefei 512
Lawrence 457
Princeton 457
Lauterbourg 440
Ho Chi Minh City 423
Beijing 388
New York 352
Milan 297
Santa Clara 231
São Paulo 211
Hanoi 203
Los Angeles 178
Nuremberg 147
Helsinki 124
Dublin 100
Rio de Janeiro 97
Rome 96
Munich 79
Boardman 75
Tokyo 69
Orem 67
Brooklyn 60
Chicago 60
Belo Horizonte 56
Vienna 56
London 55
Montreal 54
Chennai 53
Biên Hòa 50
Warsaw 50
Phoenix 48
Toronto 48
Mexico City 43
Atlanta 42
Denver 42
The Dalles 42
Brasília 41
Guangzhou 40
Guayaquil 40
Houston 40
Poplar 39
Haiphong 38
Turku 38
Buffalo 37
Curitiba 37
Da Nang 37
Frankfurt am Main 37
Johannesburg 36
Quito 35
Boston 34
Omaha 34
Porto Alegre 34
Stockholm 34
Seattle 33
Naples 32
Bologna 31
Tianjin 31
Washington 31
Mumbai 30
Campinas 28
Salvador 28
Dhaka 27
Manchester 27
Baghdad 26
Jakarta 25
Nairobi 25
San Francisco 25
Tashkent 25
Asunción 24
Shenzhen 24
Sorocaba 24
Columbus 23
Hangzhou 23
Goiânia 22
Hải Dương 22
Osasco 21
Pune 21
Brescia 20
Cesano Boscone 20
Charlotte 20
Las Vegas 20
Ankara 19
Juiz de Fora 19
Ninh Bình 19
Thái Bình 19
Amsterdam 18
Leicester 18
Santiago 18
Buenos Aires 17
Guarulhos 17
Querétaro 17
Thái Nguyên 17
Totale 16.216
Nome #
Definition, diagnosis, and management of intravascular large B-Cell lymphoma: Proposals and perspectives from an international consensus meeting 393
Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma 257
3D-culture of CLL cells in bioreactor identifies the bone marrow as a key regulator of HS1 function in response to Ibrutinib 213
Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination 211
EA4HP24-LYWS-293 An indolent EBV-related clonal T-cell proliferation presenting as chronic rhinosinusitis 203
[Clinical value of spleen autograft]. FT Considerazioni sul valore clinico dell'autoinnesto di milza 191
Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy 181
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 178
A multicenter study of treatment of primary CNS lymphoma 166
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 159
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the “CARMEN” phase II trial 154
ABS0671 IgG4-RELATED DISEASE IN OVERLAP WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: CLINICAL-PATHOLOGICAL CHARACTERISTICS AND THERAPEUTIC IMPLICATIONS OF AN ORPHAN DISEASE 154
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 153
A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression 152
3D co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents 151
BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome 149
CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF HIGH-GRADE B-CELL LYMPHOMAS TRANSFORMED FROM INDOLENT LYMPHOMAS IN HIV-NEGATIVE AND HIV-POSITIVE PATIENTS 145
THREE-HOUR INFUSION OF METHOTREXATE AT 3 g/m2 SIGNIFICANTLY REDUCES CNS RELAPSES AND IMPROVES SURVIVAL IN PATIENTS WITH LARGE B-CELL LYMPHOMAS AND INCREASED CNS RISK 145
Follicular helper T cell signature of replicative exhaustion, apoptosis and senescence in common variable immunodeficiency 139
A Mechanistic Role For Mir-126, a Hematopoietic Stem Cell Microrna, In Acute Leukemias 138
A MULTICENTER TRIAL ASSESSING FEASIBILITY AND EFFICACY OF A COMBINATION OF HIGH-DOSE METHOTREXATE, CYTARABINE AND THIOTEPA IN PATIENTS WITH PRIMARY CNS LYMPHOMA: IMPACT ON OUTCOME OF CYTARABINE DOSE 135
A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia 132
A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL 130
A PHASE II STUDY TO INVESTIGATE THE PREVALENCE OF INFECTIOUS AGENTS IN OCULAR ADNEXAE MARGINAL ZONE LYMPHOMA (OAMZL) AND THE EFFICACY OF ANTIBIOTIC THERAPY (IELSG#27 TRIAL) 130
A novel Rag2(-/-)gamma(-/-)(c)-xenograft model of human CLL 128
Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients 126
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 126
In vitro models of the crosstalk between multiple myeloma and stromal cells recapitulate the mild NF-κB activation observed in vivo 125
A bitter effect: thrombocytopenia induced by a quinidine-containing beverage 124
Immune Regulatory Neural Stem/Precursor Cells Protect from Central Nervous System Autoimmunity by Restraining Dendritic Cell Function 121
Central nervous system marginal zone B-cell lymphoma associated with chlamydophila psittaci infection 121
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: Final results of a phase 2 trial 120
A virtual tissue bank for primary central nervous system lymphomas in immunocompetent individuals 119
A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit: A position paper from the Italian Group of Haematopathology (G.I.E.) 119
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome 118
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 117
Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort 116
Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma 115
A screening study of Chlamydia psittaci infection in 172 cases of nodal and extranodal non-hodgkin lymphomas 114
SHORT-TERM DOSE-DENSE “CARMEN” THERAPY IS BETTER TOLERATED AND EVENLY EFFECTIVE THAN OTHER INTENSIFIED REGIMENS IN HIV- AND HIV+ PATIENTS WITH BURKITT LYMHOMA 113
Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models 113
A Six-Month Regimen of Oral Clarithromycin Is a Feasible and Active Therapy for Patients with Relapsed/Refractory Marginal Zone B-Cell Lymphoma of MALT-Type 113
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies 111
Bone marrow as an alternative site for islet transplantation 111
Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models 111
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 111
Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation 109
In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor 107
A woman and her canary: a tale of chlamydiae and lymphomas 107
Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects 106
Anti-CD20 monoclonal antibody (Rituximab) in gastric extranodal marginal zone (MALT) non-Hodgkin's lymphoma (NHL) patients: Clinical and biological results (Phase II study). 106
Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells 106
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: Results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial 106
ORBIT IRRADIATION AS SALVAGE TREATMENT FOR PATIENTS WITH OCULAR ADNEXAL MALT LYMPHOMA (OAML) RELAPSED AFTER OR REFRACTORY TO CHLAMYDIA PSITTACI-ERADICATING ANTIBIOTIC THERAPY 105
Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia 105
Chronic lymphocytic leukemia: the pathologist's view of lymph node microenvironment 105
A PHASE II TRIAL TO INVESTIGATE THE LINK WITH INFECTIOUS AGENTS IN OCULAR ADNEXAL MARGINAL ZONE LYMPHOMA, ESPECIALLY WITH CHLAMYDIA SPECIES, AND THE ANTINEOPLASTIC EFFECTS OF DOXYCYCLINE (IELSG#27) 105
DNA methylation alterations in prostate cancer: from diagnosis to treatment 104
Immune profiling and quantitative analysis decipher the clinical role of immune-checkpoint expression in the tumor immune microenvironment of DLBCL 104
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial 103
Graft-versus leukemia effect of HLA-haploidentical central-memory T cells expanded with leukemic APCs and modified with a suicide gene 103
Aggressive B-cell lymphoma with MYC/TP53 dual alterations displays distinct clinicopathobiological features and response to novel targeted agents 102
Autologous Pancreatic Islet Transplantation in Human Bone Marrow 102
Salvage Irradiation for Ocular Adnexal Mucosa Associated Lymphoid Tissue Lymphoma Refractory to Chlamydia psittaci Eradication 102
Primary central nervous system lymphoma 102
EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine 101
CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming 100
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 100
The impact of histopathologic diagnosis on the proper management of testis neoplasms 99
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment 98
CD4+T cells sustain aggressive chronic lymphocytic leukemia in Em- TCL1 mice through a CD40L-independent mechanism 98
A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma 97
Activity of rituximab in extranodal marginal zone lymphomas (MALT-type). 97
Kikuchi-Fujimoto Disease Shows Frequent T-Cell Antigen Loss and MUM1 Expression in Cytotoxic T Cells: a Multi-institutional Italian Study 96
Bone Marrow Histopathology in the Diagnostic Evaluation of Splenic Marginal-zone and Splenic Diffuse Red Pulp Small B-cell Lymphoma: A Reliable Substitute for Spleen Histopathology? 96
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 96
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation 95
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study 95
Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type 94
Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis 94
T-N/SCM Pre-Selection Generates CAR T Cell Products Driving Superior Anti-Tumor Responses While Curtailing Severe CRS 93
ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies 92
Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center 92
Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia 92
Gene Expression Profiling Uncovers Molecular Classifiers for the Recognition of Anaplastic Large-Cell Lymphoma Within Peripheral T-Cell Neoplasms 91
Plasma cells require autophagy for sustainable immunoglobulin production 91
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma 91
FEASIBILITY AND EFFICACY OF CHLAMYDIA PSITTACI ERADICATION WITH PROLONGED DOXYCYCLINE THERAPY IN LOCALIZED OCULAR ADNEXAE MARGINAL ZONE LYMPHOMA (OAMZL): 7-YEAR RESULTS OF THE IELSG39 MULTICENTER TRIAL 90
Role of next-generation sequencing in acquired amegakaryocytic thrombocytopenic purpura 90
Erratum: Autologous pancreatic islet transplantation in human bone marrow (Diabetes (2013) 62 (3523-3531)) 88
Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis 88
Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myeloma 88
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 87
Accelerated progression to AIDS in macaques coinfected with simian immunodeficiency virus and human herpesvirus 6A 87
Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality 87
Chlamydia infection and lymphoma: Multiple detection methods highlight an association beyond lymphomas of the ocular adnexa 87
Implications of recent molecular achievements in early diagnosis and precision treatments for primary CNS lymphoma 86
Atypical presentation of Churg-Strauss syndrome or an undescribed hypereosinophilic disease? 86
Subretinal lavage during diagnostic vitrectomy: an adjunctive technique for cell sampling in suspected vitreoretinal lymphoma 85
Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications 84
Totale 11.971
Categoria #
all - tutte 220.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 220.821


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022303 0 0 2 146 11 12 26 41 10 15 7 33
2022/20232.400 1.054 461 121 10 21 278 117 164 90 27 22 35
2023/20241.220 70 66 97 129 118 223 63 92 32 57 67 206
2024/20256.419 796 102 90 181 169 500 737 513 1.234 1.092 485 520
2025/202621.607 1.425 1.979 2.109 3.201 1.288 548 1.666 1.464 5.516 1.055 630 726
2026/20271.994 951 1.043 0 0 0 0 0 0 0 0 0 0
Totale 34.107